Millipore Sigma Vibrant Logo

375095 Heparin, Sodium Salt, Porcine Intestinal Mucosa - CAS 2608411 - Calbiochem

SDB (Sicherheitsdatenblätter), Analysenzertifikate und Qualitätszertifikate, Dossiers, Broschüren und andere verfügbare Dokumente.

Synonyme: HEP, Na

View Products on Sigmaaldrich.com
375095
  
Preis wird abgerufen...
Preis nicht abrufbar
Die Mindestmenge muss ein Vielfaches sein von
Maximum Quantity is
Bei Bestätigung Weitere Informationen
Sie haben () gespart
 
—
Bitte erfragen
—
Erfüllung und Lieferung verzögert Erfüllung und Lieferung verzögert
Lieferbar 
Produkt wurde eingestellt
Begrenzter Lagerbestand
Bestätigung der Verfügbarkeit erforderlich
    Restmenge: Angebot folgt
      Restmenge: Angebot folgt
      Bitte erfragen
      Kontakt zum Kundenservice
      Contact Customer Service

       

      Kontakt zum Kundenservice

      Übersicht

      Replacement Information

      Key Spec Table

      CAS #
      9041-08-1
      Description
      OverviewPreservative-free, non-sterile. Highly sulfated dextrorotatory mucopolysaccharide with specific anticoagulant properties. Inhibits the IP3-activated Ca2+ channel release of the endoplasmic reticulum. Reported to activate the ryanodine receptor. Note: 1 KU = 1000 units.
      MW: 15,000 ± 2,000
      M.W. 13,500-15,000. Note: 1 KU = 1000 units.
      Catalogue Number375095
      Brand Family Calbiochem®
      SynonymsHEP, Na
      References
      ReferencesSeuwen, K., and Boddeke, H.G. 1995. Br. J. Pharmacol. 114, 1613.
      Ehrlich, B.E., et al. 1994. Trends Pharmacol. Sci. 15,145.
      Product Information
      CAS number9041-08-1
      Activity≥160 USP units/mg dry weight
      FormLyophilized
      Quality SegmentMQ100
      Applications
      Biological Information
      Physicochemical Information
      ContaminantsEndotoxin: ≤0.5 EU/mg
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      RTECSMI0850000
      Safety Information
      R PhraseR: 22

      Harmful if swallowed.
      S PhraseS: 36

      Wear suitable protective clothing.
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Ambient Temperature Only
      Toxicity Harmful
      Storage +15°C to +30°C
      Do not freeze Ok to freeze
      Canadian export regulations Due to the country and/or U.S. state of origin of the animal material used in this product, this product may not be exported to Canada.
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade ITEM Number
      Bestellnummer GTIN
      375095 0

      Documentation

      Heparin, Sodium Salt, Porcine Intestinal Mucosa - CAS 2608411 - Calbiochem SDB

      Titel

      Sicherheitsdatenblatt (SDB) 

      Heparin, Sodium Salt, Porcine Intestinal Mucosa - CAS 2608411 - Calbiochem Analysenzertifikate

      TitelChargennummer
      375095

      Literatur

      Übersicht
      Seuwen, K., and Boddeke, H.G. 1995. Br. J. Pharmacol. 114, 1613.
      Ehrlich, B.E., et al. 1994. Trends Pharmacol. Sci. 15,145.
      Datenblatt

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision18-October-2018 JSW
      SynonymsHEP, Na
      DescriptionPreservative-free, non-sterile. Highly sulfated dextrorotatory mucopolysaccharide with specific anticoagulant properties. Inhibits IP3-activated Ca2+ channel release of the endoplasmic reticulum. Reported to activate the ryanodine receptor. Note: 1 KU = 1000 units. MW: 15,000 ± 2,000.
      FormLyophilized
      CAS number9041-08-1
      RTECSMI0850000
      ContaminantsEndotoxin: ≤0.5 EU/mg
      Activity≥160 USP units/mg dry weight
      SolubilityH₂O (50 mg/ml)
      Storage +15°C to +30°C
      Do Not Freeze Ok to freeze
      Toxicity Harmful
      Merck USA index14, 4653
      ReferencesSeuwen, K., and Boddeke, H.G. 1995. Br. J. Pharmacol. 114, 1613.
      Ehrlich, B.E., et al. 1994. Trends Pharmacol. Sci. 15,145.